Health Canada drug identification number

DIN 02244826 — TNKASE 50 MG

TNKASE is a powder for solution of Tenecteplase marketed by HOFFMANN-LA ROCHE LIMITED. The full Tenecteplase monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02244826
Brand name
TNKASE
Active ingredient
Tenecteplase
Strength
50 MG
Dosage form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Manufacturer
HOFFMANN-LA ROCHE LIMITED
Health Canada status
MARKETED
Drug class
Fibrinolytic agent (tissue plasminogen activator)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Tenecteplase products

DINBrandStrengthFormManufacturerStatus
02562804 TNKASE 25 MG POWDER FOR SOLUTION HOFFMANN-LA ROCHE LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.